| Literature DB >> 34030486 |
Michael A Fuchs1, Ami G Multani1,2,3, Kenneth H Mayer1,3,4, Alex S Keuroghlian5,4,6.
Abstract
Anal cancer is a rare disease that disproportionately affects people living with HIV and men who have sex with men (MSM). Although screening of MSM living with HIV occurs in the absence of consistent national guidelines, less research exists on screening HIV-negative MSM. In this article, we discuss patient-, clinician-, and systems-level factors that may influence decisions to screen HIV-negative MSM. Randomized controlled trials with MSM living with HIV and those at high risk are in progress, yet more research is needed to address clinical uncertainty around screening additional at-risk groups.Entities:
Keywords: HIV; anal cancer; human papillomavirus (HPV); men who have sex with men (MSM); prevention; screening
Year: 2021 PMID: 34030486 PMCID: PMC8252895 DOI: 10.1089/lgbt.2020.0257
Source DB: PubMed Journal: LGBT Health ISSN: 2325-8292 Impact factor: 4.151